Exposure–Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD

Background Recombinant von Willebrand factor (rVWF, vonicog alfa, Takeda Pharmaceuticals USA) is indicated in adults diagnosed with von Willebrand disease (VWD). In this study, the exposure–response (ER) relationship between VWF activity (VWF:RCo) or factor VIII activity (FVIII:C) and spo...

Descrición completa

Detalles Bibliográficos

Principais autores:	Frank W.G. Leebeek, Giancarlo Castaman, Jean François Marier, Gülden Özen, Indranil Bhattacharya, Jingmei Zhang, Scarlett Wang, Yi Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Georg Thieme Verlag KG 2024-04-01
Series:	TH Open
Assuntos:	bleeding prophylaxis recombinant VWF vonicog alfa von Willebrand disease factor VIII
Acceso en liña:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1787815
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!